The 20 Best Classical Hodgkin Lymphoma Doctors Near Me in Livingston, NJ

With his many speaking engagements and commitment to education, Dr. Neil Morganstein has a reputation as a leader in the treatment of hematological and oncological issues. He is a national speaker in the area of multiple myeloma, as well as co-chair of a video conference on the management of patients with multiple myeloma. He has a special interest in lung cancer and multiple myeloma, and has published and presented several peer-reviewed articles, posters and abstracts at regional and national oncology meetings. These have focused on multiple myeloma, lymphoma, prostate cancer, gastric cancer, and hematological complications during pregnancy.As an involved and committed oncologist at Overlook Medical Center’s Carol G. Simon Cancer Center, Dr. Morganstein gives several lectures a year educating medical students. He teaches the hematology board review course for the American College of Physicians, as well as the hematology and oncology course for residents at Rutgers University. In addition, he thoroughly enjoys working with medical students in the hospital.Dr. Morganstein completed his hematology and oncology fellowship at Robert Wood Johnson University Hospital of New Brunswick, New Jersey, where he also finished his residency training, while serving as chief resident. He is board-certified in medical oncology, hematology and internal medicine and maintains membership in many distinguished organizations, including the American Society of Clinical Oncologists and the American Society of Hematologists. Dr. Morganstein is rated as a Distinguished provider by MediFind in the treatment of Classical Hodgkin Lymphoma. His top areas of expertise are Large-Cell Immunoblastic Lymphoma, Classical Hodgkin Lymphoma, Hodgkin Lymphoma, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Bone Marrow Aspiration.

Ashish Ashvin Shah, DO, MSc, is a fellowship-trained hematologist/oncologist with Advanced Care Oncology and Hematology (ACOHA), part of Atlantic Medical Group (AMG). Board-certified in medical oncology and hematology by the American Board of Internal Medicine, he has more than 15 years of experience treating blood diseases and various forms of cancer. Dr. Shah’s clinical interests span a wide spectrum, from acute and chronic leukemia to lymphoma, multiple myeloma, myelodysplastic disease, and various types of cancer, including lung, colorectal, breast, ovarian, and neuroendocrine tumors. He has extensive knowledge and experience in these conditions.After earning his osteopathic medicine degree from Philadelphia College of Osteopathic Medicine, Dr. Shah completed an internal medicine residency at Robert Wood Johnson University Hospital in New Brunswick, NJ. He completed a hematology and oncology fellowship also at Robert Wood Johnson. Previously, he completed a Master of Science (MSc) degree in neuroscience at Southern Connecticut State University.Prior to joining AMG, Dr. Shah served as director of leukemia/lymphoma services and co-director of the adolescent and young adult oncology program at Lehigh Valley Health Network in Bethlehem, Pennsylvania for seven years. He also served as a clinical assistant professor of medicine at the University of South Florida’s Morsani College of Medicine in Tampa. Dr. Shah joined ACOHA in 2016.Dr. Shah is a member of the American Society of Clinical Oncology, American Society of Hematology, American Osteopathic Association, and American Association of Physicians from India. He is a participating provider of the Atlantic Accountable Care Organization. Dr. Shah is rated as an Experienced provider by MediFind in the treatment of Classical Hodgkin Lymphoma. His top areas of expertise are Iron Deficiency Anemia, Large-Cell Immunoblastic Lymphoma, Childhood Iron Deficiency Anemia, Acute Myeloid Leukemia (AML), and Bone Marrow Aspiration.

Dr. Sonyo Shin is an esteemed attending hematologist/oncologist at Advanced Care Oncology and Hematology Associates (ACOHA), a distinguished part of Atlantic Medical Group (AMG). With over 20 years of dedicated experience in the field, she is deeply committed to delivering patient-centered care in both hematology and oncology.Dr. Shin is board-certified in internal medicine, oncology, and hematology by the American Board of Internal Medicine. Her extensive expertise encompasses the treatment of a wide range of malignancies, including lymphoma, lung cancer, and chronic leukemia. She has been instrumental in developing and leading multidisciplinary breast cancer clinics, ensuring a comprehensive approach to patient care.In addition to her clinical practice, Dr. Shin is actively involved in clinical trials, contributing to the advancement of cancer research. She is also passionate about education, mentoring medical residents and students to foster the next generation of healthcare professionals. Her commitment to excellence in patient care and education underscores her role as a leader in the field of hematology and oncology. Dr. Shin is rated as a Distinguished provider by MediFind in the treatment of Classical Hodgkin Lymphoma. Her top areas of expertise are Paget Disease of the Breast, Familial Colorectal Cancer, Small Cell Lung Cancer (SCLC), and Lung Adenocarcinoma.

Shalini Chhabra is a Radiologist in Livingston, New Jersey. Dr. Chhabra is rated as an Experienced provider by MediFind in the treatment of Classical Hodgkin Lymphoma. Her top areas of expertise are Gastric Lymphoma, Lymphoid Hyperplasia, Lymphofollicular Hyperplasia, and Metastatic Pleural Tumor.

Mark Laible is a Radiologist in Livingston, New Jersey. Dr. Laible is rated as an Experienced provider by MediFind in the treatment of Classical Hodgkin Lymphoma. His top areas of expertise are Gastric Lymphoma, Meningioma, Carbuncle, and Folliculitis.

Said Saleh is a Hematologist in West Orange, New Jersey. Dr. Saleh is rated as an Experienced provider by MediFind in the treatment of Classical Hodgkin Lymphoma. His top areas of expertise are Iron Deficiency Anemia, Thrombocytopenia, Childhood Iron Deficiency Anemia, Anemia, and Endoscopy.

Eric Teller is a Pulmonary Medicine provider in Millburn, New Jersey. Dr. Teller is rated as an Experienced provider by MediFind in the treatment of Classical Hodgkin Lymphoma. His top areas of expertise are Lung Metastases, Obstructive Sleep Apnea, Bronchiectasis, and Chronic Obstructive Pulmonary Disease (COPD).

Dr. Michael Scola is a board-certified, fellowship-trained hematologist oncologist practicing at Atlantic Hematology Oncology located at Morristown Medical Center. For the past 20 years, Dr. Scola has maintained a broad-based clinical practice, with a focus on benign and malignant hematology. He is currently director of the new Atlantic Thrombosis Center, designed to investigate and manage patients with a variety of bleeding and clotting disorders. Dr. Scola is a skilled and compassionate physician. His postdoctoral training includes a fellowship in hematology oncology from Boston University Medical Center, where he received the Outstanding Fellow award and the Chiefs’ Hematology Award for clinical excellence. He received his medical degree from Baylor College of Medicine in Houston, TX. A teacher and mentor, Dr. Scola served many years as course director of pathophysiology at Northeastern University, Boston, and is actively involved in instructing residents at Morristown Medical Center. He is also involved in clinical research; has worked within the industry as a consultant, lecturer and advisor; and has authored articles and book chapters. Dr. Scola’s education includes a year spent abroad in Florence, Italy, and an intensive post-training program in clinical research at the Harvard School of Public Health. He serves on the boards of the Cancer Hope Network, and the Cancer Support Community of Central New Jersey. Dr. Scola is a member of the American Society of Hematology, American Society of Clinical Oncology and the International Society of Thrombosis and Hemostasis. Dr. Scola is rated as an Advanced provider by MediFind in the treatment of Classical Hodgkin Lymphoma. His top areas of expertise are Philadelphia-Negative Chronic Myeloid Leukemia, Chronic Myelogenous Leukemia (CML), Non-Hodgkin Lymphoma, Anemia, and Bone Marrow Aspiration.

Dr. Charles Farber is a board-certified, fellowship-trained oncologist at Atlantic Hematology Oncology located at Morristown Medical Center’s Carol G. Simon Cancer Center. He maintains a broad-based practice, yet focuses on benign and malignant hematology. Dr. Farber also serves as medical director of Oncology Research Network Development for Atlantic Health System. In this role, he works with the system’s Breakthrough Oncology Accelerator partners, Translational Genomics Research Institute (TGen) and OriginCV, to expand cancer research at Morristown Medical Center and throughout Atlantic Health System. This partnership ensures that patients have access to the newest and most exciting drugs and technologies through clinical trials. In addition to receiving multiple Patient’s Choice Awards, Dr. Farber has been recognized as a Top Doctor in the New York Metro Area, and listed in Inside Jersey magazine’s Top Doctors, and Consumers Research Council’s Guide to America’s Top Oncologists. He is regarded by colleagues and patients as a knowledgeable, compassionate and devoted physician and has been providing expert care to the Morristown community for more than 20 years. Dr. Farber attended New York University School of Medicine for his medical degree and performed his residency and fellowship at Weill Cornell Medical Center. He also earned a master’s degree and PhD from New York University’s Graduate School of Arts and Sciences. Dr. Farber chairs Morristown Medical Center’s cancer subcommittee for adolescents and young adults and serves as secretary and treasurer of the Oncology Society of New Jersey. He was former chief of the division of Hematology/Oncology at Morristown Medical Center from 2007 to 2011. Dr. Farber serves as a clinical assistant professor at Rutgers and at the Cancer Institute of New Jersey. His research has been published in the Journal of the American Nutraceutical Association, the New England Journal of Medicine and the National Cancer Institute’s Clinical Trial Directory. Dr. Farber is rated as an Advanced provider by MediFind in the treatment of Classical Hodgkin Lymphoma. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Non-Hodgkin Lymphoma, Follicular Lymphoma, and Bone Marrow Aspiration.

Israel Grossman is an Oncologist in Livingston, New Jersey. Dr. Grossman is rated as an Advanced provider by MediFind in the treatment of Classical Hodgkin Lymphoma. His top areas of expertise are Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), Plasmacytoma, Hodgkin Lymphoma, Marginal Zone Lymphoma (MZL), and Bone Marrow Aspiration. Dr. Grossman is currently accepting new patients.

Michael Stubblefield is an Internal Medicine provider in West Orange, New Jersey. Dr. Stubblefield is rated as an Advanced provider by MediFind in the treatment of Classical Hodgkin Lymphoma. His top areas of expertise are Lymphedema, Meige Disease, Primary Intestinal Lymphangiectasia, and Lymphangiectasis.

Ahmed Galal is a Hematologist and an Oncologist in Springfield, New Jersey. Dr. Galal is rated as an Advanced provider by MediFind in the treatment of Classical Hodgkin Lymphoma. His top areas of expertise are Mantle Cell Lymphoma (MCL), Diffuse Large B-Cell Lymphoma (DLBCL), Large-Cell Immunoblastic Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant.

Dr. Dennis Lowenthal has dedicated his career to caring for cancer patients, particularly those with lung cancer. He is the medical director of Medical Diagnostics Associates Hematology and Oncology, which is part of the Atlantic Medical Group. He also serves as medical director of Atlantic Health System’s Carol G. Simon Cancer Center at Overlook Medical Center.Growing up in the Bronx, NY, Dr. Lowenthal attended the State University of New York at Buffalo where he graduated magna cum laude with a BA in biology. He earned his medical degree at Boston University School of Medicine, continued with a medical internship at the Cleveland Clinic, and returned to the Bronx to complete his medical residency and a hematology fellowship at Montefiore Hospital and Medical Center of the Albert Einstein College of Medicine. He subsequently completed a clinical Blood Bank Directors fellowship at the New York Blood Center and then went on to complete a medical oncology fellowship at Memorial Sloan-Kettering Cancer Center where he served as Chief Fellow and Special Clinical Fellow in AIDS-related malignancies.Dr. Lowenthal considers coming to Overlook Medical Center 32 years ago one of his best life decisions, working with his colleagues to help create the Carol G. Simon Cancer Center at Overlook Medical Center. He serves as chairman of the hospital’s Cancer Committee and Cancer Center Executive Committee, and has been the long-standing section chief for Hematology/Oncology. He is co-chairman of Thoracic Oncology and the Thoracic Tumor Board at Atlantic Health System and is the principal investigator for lung cancer clinical trials conducted at Overlook Medical Center – specifically, serving as the principal investigator for the first immunotherapy approved for the treatment of lung cancer. Dr. Lowenthal is a past recipient of Overlook’s Physician Excellence in Clinical Practice award and has been an associate professor of Clinical Medicine at Columbia University College of Physicians and Surgeons, Mount Sinai School of Medicine, and currently the Sidney Kimmel Medical College at Thomas Jefferson University. Dr. Lowenthal is rated as an Experienced provider by MediFind in the treatment of Classical Hodgkin Lymphoma. His top areas of expertise are Pleuropulmonary Blastoma, Lung Adenocarcinoma, Squamous Cell Lung Carcinoma, and Small Cell Lung Cancer (SCLC).

Triple board-certified in internal medicine, hematology and medical oncology, Dr. Mohamad Cherry is medical director of Hematology at Atlantic Health System. He joins Atlantic Hematology Oncology from the University of Oklahoma Health Sciences Center's Stephenson Cancer Center, bringing years of clinical knowledge and expertise.With specialty training from some of the nation's most skilled clinicians, Dr. Cherry attained some of his clinical training at the leukemia department at MD Anderson and his fellowship in hematology/oncology from the University of Oklahoma Health Sciences Center's Stephenson Cancer Center. He performed two residencies - an internal medicine residency at Staten Island University Hospital and a laboratory medicine residency at the American University of Beirut Medical Center in Lebanon. Previously, Dr. Cherry attained his medical degree at Lebanese University and performed his internship at Sacre Coeur Hospital-Lebanese University. He also earned a master of science degree in clinical and translational research from University of Oklahoma College of Public Health.Dr. Cherry remains on staff as clinical associate professor of hematology/oncology at University of Oklahoma Health Sciences Center's Stephenson Cancer Center. He is also the director of its hematology/oncology fellowship program and co-chairs the Academy of Teaching Scholars Faculty Development, Education and Mentoring Committee. Other administrative roles include co-chair of the leukemia working group at the Sarah Cannon Research Institute Blood Cancer Consortium.As a principal investigator of multiple clinical trials, Dr. Cherry has performed groundbreaking research in niche areas that include epigenetics and development of new therapeutics in relapsed and refractory blood cancers. He has developed teaching materials and book chapters, and has lectured both nationally and internationally.Dr. Cherry continues to serves as a mentor and an advisor to fellows, residents and medical students. He contributes to continuing education, public health, and professional development, and has won awards and funding for both his research and his clinical pursuits. Dr. Cherry is rated as an Experienced provider by MediFind in the treatment of Classical Hodgkin Lymphoma. His top areas of expertise are Acute Myeloid Leukemia (AML), Non-Hodgkin Lymphoma, Acute Myeloblastic Leukemia without Maturation, Midline Lethal Granuloma, and Bone Marrow Aspiration.

Karim R. Saab, MD, is a fellowship-trained hematology oncology specialist with Atlantic Medical Group Hematology Oncology. Triple board-certified in internal medicine, medical oncology, and hematology by the American Board of Internal Medicine, Dr. Saab has years of teaching experience and clinical knowledge.After graduating with distinction from the School of Medicine at the American University of Beirut, Lebanon, Dr. Saab served as a research scholar and postdoctoral research fellow in the Department of Surgery at St. Jude Children’s Research Hospital, Memphis, TN, followed by two years as a postdoctoral research fellow at Harvard Medical School, Brigham and Women’s Hospital, and Children’s Hospital Boston, Transplantation Research Center, Boston, MA. He performed his residency in internal medicine at the University of Colorado, Aurora, CO, where he was awarded the internal medicine resident research publication award, followed by a fellowship in hematology and medical oncology at Weill Cornell Medical College / New York-Presbyterian Hospital, New York, NY.Before joining Atlantic Medical Group Hematology Oncology, Dr. Saab worked at Hennepin Healthcare in Minneapolis, MN, where he also served as assistant professor of medicine at the University of Minnesota. Dr. Saab has been involved in teaching hematology and medical oncology fellows, residents, medical and physician assistant students, as well as teaching medical students at Weill Cornell Medical College. Actively involved in research, Dr. Saab has studied biomarkers for diagnosis, disease progression and response to therapy; cancer stem cell biology; and antiangiogenic therapy for solid tumors. He has been published in many peer-reviewed journals and presented at national conferences.Dr. Saab is an active member of the American Society of Clinical Oncology, American Society of Hematology, American College of Physicians, and American Physician Scientists Association. He is fluent in French and Arabic. Dr. Saab is a participating provider of the Atlantic Accountable Care Organization. Dr. Saab is rated as an Experienced provider by MediFind in the treatment of Classical Hodgkin Lymphoma. His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, Lung Adenocarcinoma, and Large-Cell Lung Carcinoma.

Dr. Mark Widmann is chief of Thoracic Surgery at Morristown Medical Center and leads Atlantic Medical Group’s North Jersey Thoracic Surgical Associates. Board certified in thoracic surgery, Dr. Widmann offers expert subspecialty surgical care to patients with benign and malignant disorders of the lung, mediastinum, pleura, esophagus and chest wall. He has expertise in state-of-the-art, minimally-invasive techniques and has led the programs development of Video-Assisted Thoracic Surgery (VATS) and other endoscopic/laparoscopic approaches to treat conditions such as cancer, infection, pneumothorax and swallowing disorders.With a commitment to clinical excellence, Dr. Widmann leads the section of thoracic surgery at Morristown Medical Center and has been surgical director of the Lung Cancer Program at Atlantic Health’s Carol G. Simon Cancer Center since 2000. Dr. Widmann graduated magna cum laude from Duke University and went on to pursue his medical degree at Yale University School of Medicine. His post-graduate training includes NIH sponsored research fellowships in Cardiovascular disease at Yale and the University of Iowa Hospitals. He performed his residency training in general surgery at Yale-New Haven Hospital in New Haven, CT and cardiothoracic residency training at the University of Iowa Hospitals & Clinics in Iowa City, IA.Committed to resident education, Dr. Widmann serves as an assistant clinical professor of surgery at Columbia University College of Physicians and Surgeons in New York. He is a member of the Society of Thoracic Surgeons and a fellow of the American College of Surgeons and the American College of Chest Physicians and former president of the NJ Society of Thoracic Surgeons. Dr. Widmann is rated as an Experienced provider by MediFind in the treatment of Classical Hodgkin Lymphoma. His top areas of expertise are Fibrosing Mediastinitis, Pleuropulmonary Blastoma, Lung Nodules, Thymectomy, and Endoscopy.

Michael Wax is a Hematologist and an Oncologist in Berkeley Heights, New Jersey. Dr. Wax is rated as an Advanced provider by MediFind in the treatment of Classical Hodgkin Lymphoma. His top areas of expertise are Non-Hodgkin Lymphoma, Myelodysplastic Syndrome (MDS), Gastric Lymphoma, and Polycythemia Vera. Dr. Wax is currently accepting new patients.

Michael Scoppetuolo is an Oncologist in Livingston, New Jersey. Dr. Scoppetuolo is rated as an Experienced provider by MediFind in the treatment of Classical Hodgkin Lymphoma. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Colorectal Cancer, and Familial Colorectal Cancer. Dr. Scoppetuolo is currently accepting new patients.

Pat Lipari is a Nurse Practitioner in Livingston, New Jersey. Ms. Lipari is rated as an Experienced provider by MediFind in the treatment of Classical Hodgkin Lymphoma. Her top areas of expertise are BRCA Positive Breast Cancer, HER2 Negative Breast Cancer, Gallbladder Adenocarcinoma, and Smoldering Multiple Myeloma. Ms. Lipari is currently accepting new patients.

Parth Rao is a Hematologist and an Oncologist in Livingston, New Jersey. Dr. Rao is rated as an Experienced provider by MediFind in the treatment of Classical Hodgkin Lymphoma. His top areas of expertise are Hemangioma Thrombocytopenia Syndrome, Adult Immune Thrombocytopenia, Immune Thrombocytopenic Purpura (ITP), Bone Marrow Aspiration, and Bone Marrow Transplant.